Delivery Order SPE2DB20D2014-SPE2DB25FC27S
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 26, 2025, by the Defense Logistics Agency (DLA) for the supply of Trulicity 3 mg/0.5 mL pens with a ceiling value of $6,006.00. This is a firm fixed-price delivery order with an ultimate completion date of September 29, 2025. The contract is not set-aside and represents a competitive award under the company's existing indefinite delivery contract vehicle with DLA Troop Support...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 28, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens valued at $1,226.40. The contract is structured as a firm fixed price delivery order with an ultimate completion date of August 29, 2025, and carries no set-aside designation, indicating it was competitively awarded. This delivery order represents a single...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 23, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens with a ceiling value of $1,858.72. This competitive award, issued without a set-aside designation, carries a firm fixed price structure with an ultimate completion date of July 24, 2025. The product will be performed and distributed from the contractor's location in Conshohocken, Pennsylvania. This delivery order represents a child...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was awarded a delivery order by the Defense Logistics Agency (DLA) on January 23, 2026, for Trulicity 3 mg/0.5 mL pens valued at $1,582.40. The contract represents a firm fixed-price delivery order with an ultimate completion date of January 26, 2026, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation, consistent with...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on January 2, 2026, by the Defense Logistics Agency for the supply of Trulicity 0.75 mg/0.5 ml pens valued at $1,424.16. The award represents a competitive, non-set-aside contract with firm fixed pricing and is scheduled for completion by January 5, 2026. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,669.96 by the Defense Logistics Agency on July 28, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens. The contract utilizes firm fixed pricing with no set-aside designation and is scheduled for completion by July 29, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp was awarded a firm fixed price delivery order valued at $1,788.24 by the Defense Logistics Agency (DLA) on October 30, 2025, for the supply of Trulicity 3 mg/0.5 mL pens (0.5 mL). The contract, which represents a non-competitive set-aside delivery, is scheduled for completion by October 31, 2025, with performance based in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 30, 2025, for the supply of Trulicity 3 mg/0.5 mL pens valued at $1,553.26, with an ultimate completion date of July 31, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, to be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on January 21, 2026, for Trulicity 1.5 mg/0.5 ml pen injections with a ceiling value of $2,842.99 and an ultimate completion date of January 22, 2026. This award utilizes a firm fixed-price contract structure and was competitively awarded with no set-aside designation. The delivery order falls under AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,017.52 by the Defense Logistics Agency on November 24, 2025, with completion targeted for November 25, 2025. The contract (4570091594) involves the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL), a diabetes medication commonly used within military and federal healthcare systems. This delivery order was competitively awarded without set-aside...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC27SDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on June 23, 2025, for the supply of Trulicity 3 mg/0.5 ml pens. The contract carries a ceiling value of $5,723.04 and features firm fixed-price pricing with an ultimate completion date of June 24, 2025. This is an unset-aside, competitively awarded delivery order representing a single-line item pharmaceutical procurement. This delivery order operates as a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The underlying IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to military healthcare programs and other federal health systems worldwide. The specific award of Trulicity—a diabetes medication—reflects the contractor's established capability to fulfill federal pharmaceutical procurement requirements across multiple therapeutic domains, including specialty and brand-name medications essential to Defense Health Agency operations and other government healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.7k | 6/23/25 |